Lactobacilli and bifidobacteria derived from infant intestines may activate macrophages and lead to different IL-10 secretion
- Biosci Biotechnol Biochem. 2020 Dec;84(12):2558-2568. doi: 10.1080/09168451.2020.1811948.
- 1. Department of Nutrition, Food Hygiene and Toxicology, West China School of Public Health and West China Fourth Hospital, Sichuan University , Chengdu, China.
- 2. Nutrition and Health Research Centre, By-Health Co., Ltd , Guangzhou, China.
- 3. Department of Pathogenic Biology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University , Chengdu, China.
In this study, three strains of lactobacilli and bifidobacteria originally isolated from healthy infants, were tested for their abilities to activate RAW264.7 cells. Gene expression and cytokine production of interleukin-10 (IL-10) of RAW264.7 cells were evaluated. The activation of extracellular regulated protein kinases 1/2 (ERK1/2), p38, and nuclear factor-κB (NK-κB) were also assessed. These results suggest lactobacilli and bifidobacteria in infants may promote production of IL-10 in macrophages, conferring a protective effect in hosts suffering from inflammation. Dimerization of TLR2 and MyD88 and subsequent phosphorylation of the key downstream signaling molecules, such as MAPKs and NK-κB, may be one of the key underlying mechanisms of activation of macrophages by these microbes. Bifidobacteria and lactobacilli induced macrophages to secrete IL-10 in a different manner, which may relate to their abilities to activate key signaling pathways mediated by TLR2 and MyD88.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Toll-like Receptor (TLR)Research Areas: Inflammation/Immunology